BVMT: UMED Statistics

Total Valuation

Unité de Fabrication des Médicaments S.A has a market cap or net worth of TND 225.60 million. The enterprise value is 246.30 million.

Market Cap	225.60M
Enterprise Value	246.30M

Important Dates

The last earnings date was Friday, December 20, 2024.

Earnings Date	Dec 20, 2024
Ex-Dividend Date	n/a

Share Statistics

Unité de Fabrication des Médicaments S.A has 32.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	32.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 35.07 and the forward PE ratio is 10.68.

PE Ratio	35.07
Forward PE	10.68
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.27
P/FCF Ratio	11.57
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.94, with an EV/FCF ratio of 12.63.

EV / Earnings	38.29
EV / Sales	1.75
EV / EBITDA	5.94
EV / EBIT	8.06
EV / FCF	12.63

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.31.

Current Ratio	1.86
Quick Ratio	0.80
Debt / Equity	0.31
Debt / EBITDA	0.75
Debt / FCF	1.61
Interest Coverage	4.72

Financial Efficiency

Return on equity (ROE) is 6.52% and return on invested capital (ROIC) is 13.68%.

Return on Equity (ROE)	6.52%
Return on Assets (ROA)	10.27%
Return on Capital (ROIC)	13.68%
Revenue Per Employee	246,629
Profits Per Employee	11,246
Employee Count	572
Asset Turnover	0.76
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.08%
50-Day Moving Average	7.19
200-Day Moving Average	7.09
Relative Strength Index (RSI)	38.91
Average Volume (20 Days)	2,444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Unité de Fabrication des Médicaments S.A had revenue of TND 141.07 million and earned 6.43 million in profits.

Revenue	141.07M
Gross Profit	77.98M
Operating Income	30.57M
Pretax Income	12.20M
Net Income	6.43M
EBITDA	41.49M
EBIT	30.57M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 10.62 million in cash and 31.32 million in debt, giving a net cash position of -20.70 million or -0.65 per share.

Cash & Cash Equivalents	10.62M
Total Debt	31.32M
Net Cash	-20.70M
Net Cash Per Share	-0.65
Equity (Book Value)	101.84M
Book Value Per Share	n/a
Working Capital	49.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.14 million and capital expenditures -6.65 million, giving a free cash flow of 19.50 million.

Operating Cash Flow	26.14M
Capital Expenditures	-6.65M
Free Cash Flow	19.50M
FCF Per Share	0.61

Full Cash Flow Statement

Margins

Gross margin is 55.27%, with operating and profit margins of 21.67% and 4.56%.

Gross Margin	55.27%
Operating Margin	21.67%
Pretax Margin	8.65%
Profit Margin	4.56%
EBITDA Margin	29.41%
EBIT Margin	21.67%
FCF Margin	13.82%

Dividends & Yields

Unité de Fabrication des Médicaments S.A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	233.27%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	8.64%

Dividend Details

Stock Splits

The last stock split was on August 4, 2017. It was a forward split with a ratio of 1.0940200862.

Last Split Date	Aug 4, 2017
Split Type	Forward
Split Ratio	1.0940200862

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a